Our mission is to bridge the vital link between
research breakthroughs and their commercial application
in the fields of medicine, devices and therapies
—with Certainty.
product
Certainty is a web and mobile computing application that resolves the enormous challenges facing the contemporary medical research community, and the donors who fund them.
This is reflected in our approach to
-
patient enrolments
-
data sharing and personal privacy
-
trial methodology
-
rising costs
In so doing, Certainty solves multiple underlying problems in data management, team communication, and project workflow.
company
Zero Bloc Certain Ltd is a healthcare-focused software as a service company formed to commercialise and operate Certainty, a software platform that transforms the clinical trials process into an ecosystem of connected stakeholders and unified workflows.
team
Chief Executive Officer
PRAB TAKHAR
Prab Takhar has been working in research and healthcare for over 20 years delivering results in various global positions held in Europe and Australia. As a world specialist in radiopharmaceutical manufacturing, he was most recently the Cyclotron Unit Section Chief at Linking University Hospital in Sweden.
​
Prab’s previous experience as a Director of a TGA sterile injectable manufacturing facility, combined with his experience in radiopharmaceutical’s, make Prab a leading global expert in navigating international regulations as they relate to the drug manufacturing and approval process.
​
​
Senior Principal Investigator
STEPHANE VERGHAEGHE, MD
Stephane Verghaeghe is a neurologist with extensive clinical research and development experience having worked in management capacity for Biogen, Sanofi-Aventis, Novartis, and Alexion Pharmaceuticals over the last 15 years.
Most recently Stephane was the Medical Director for Madison Pharma and is based in Sydney, Australia.
Founder / Chief Technology Officer
CHARLES ISAAC
Charles Isaac is a systems thinker, polymath, and recognised Distinguished Talent in Australia. A seasoned executive whose portfolio includes Morgan Stanley, Thomson Physicians World, Skychaser, and the U.S. Department Of Energy, Charles has pioneered innovative media and technology solutions for entrepreneurial startups, governments, and major corporations for more than 20 years.
scientific advisory board
Advisor
MARK HUTCHINSON
Prof Mark Hutchinson is the Director of the Centre for Nanoscale BioPhotonics. The CNBP is a $50M ARC Centre of Excellence that brings together researchers from around the world to create light based sensing technologies to create 'windows into the body'. These advances will enable scientific breakthroughs and advance the health outcomes of tomorrow.
​
He is President of Science and Technology Australia , the peak body in science and technology in Australia. STA represents more than 90,000 scientists and technologists as an influential voice for evidence and expertise in public policy.
​
partners
SWINBURNE
UNIVERSITY OF
TECHNOLOGY
Research & Development Partner
The Digital Research & Innovation Capability group is responsible for Swinburne’s blockchain initiatives. We have entered into a collaboration agreement that will focus on technical validation of the platform and researching the application of AI to the clinical trials space.